Topics

Companies Related to "High Throughput Surveillance Study Antibiotic Resistance Using Automated" [Most Relevant Company Matches] RSS

17:21 EDT 18th July 2019 | BioPortfolio

Here are the most relevant search results for "High Throughput Surveillance Study Antibiotic Resistance Using Automated" found in our extensive corporate database of over 50,000 company records.

Showing "High Throughput Surveillance Study Antibiotic Resistance Using Automated" Companies 1–25 of 5,400+

Relevant

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...


Ipsat Therapies Oy

Ipsat Therapies Ltd is a Finnish biotechnology company developing its proprietary IPSAT™ (“Intestinal Protection System in Antibiotic Treatment”) family of products for the prevention of hospital infections and antibiotic resistance

AdvanDx, Inc

AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE™ kits for detecting specific antibiotic resistance, virulence, and toxicity markers such as methicillin-resistance, vancomycin-resistance, PVL and TSST-1 in Staphylococcus aureus and enterococci, were launched for research use only in the United States. EVIGENE was officially launch...


Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...

Paratek Pharmaceuticals Incorporated

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has established two product development programs to identify and develop new pharmaceuticals for the treatment of infectious diseases:The Tetracycline Resistance Project ("Tet Project") based on expertise ...

Synbiosis

Synbiosis is a world leading supplier of automatic colony counting and zone measurement systems in microbiology and pharmaceutical applications. The hallmark of all Synbiosis systems is that they will improve the efficiency, reliability and productivity of any laboratory through the use of automated techniques. Synbiosis products are used in the pharmaceutical, healthcare and food manufacturing in...

Disovery Partners International

Premier partner for drug discovery, offeringtarget characterizaton, lead generation, lead optimization, medicinal, combinatorial and analytical chemistry services, automated high throughput solid and solution phase synthesis and systems, high throughput screening services, pure compound library creation, ADME Tox, and other project services. Parent company of the following:http://www.irori.comhttp...

Tierra Biosciences

Tierra Biosciences is a San Francisco-based molecule and drug discovery company founded in 2015 by Zachary Sun, Ph.D., (C.E.O.), George Church, Ph.D. (Harvard), and Richard Murray, Ph.D. (California Institute of Technology). Tierra’s proprietary cell-free technologies enable the discovery of molecules that are difficult or impossible to produce in com...

Arsanis Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Arsanis, Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Arsanis Biosciences GmbH

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Sophion Bioscience A/S

Sophion provides advanced integrated solutions for automated functional characterization of living cells.Our initial solutions, based on equipment and methodology for medium- and high-throughput ion channel screening of drug candidates, targets the pharmaceutical industry.Our vision is to be the pharmaceutical industry’s preferred partner for providing integrated solutions that rationalize the s...

Arsanis, Inc.

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is engaged in the discovery and commercialization of new therapeutics that treat serious and life-threatening diseases, with a particular focus on the growing worldwide problem of antibiotic resistance. Paratek is advancing novel compounds that can circumvent or block bacterial resistance involving technology initially developed by Paratek co-founder Dr. Stuart Levy's...

Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...

Mpex Pharmaceuticals

Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens. It is well documented that antibiotic resistance is a growing, serious problem in both the hospital and community setting. Mpex's approach is to improve the activity of existing antibiotics by utilizing methods and pot...

Syrrx Incorporated

Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered. Based in San Diego, CA, the company is at the forefront of high-throughput rational drug discovery. Syrrx intends to leverage high-throughput structure determination, high-throughput screening, combinatorial and medicinal chemistry together with computational methods to discover novel small molecule p...

LION bioscience Inc.

The Life Science industry is facing the challenge of managing the exponential increase in volume, diversity and complexity of available data generated by automated high-throughput technologies as well as the product development alternatives available.

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance. Since the company’s inception in 2006, Tetraphase has developed a robust antibiotic franchise that offers the potential to ...

NEOSPORIN(R)

NEOSPORIN® Original First Aid Antibiotic Ointment, from the #1 Doctor-recommended brand, provides long-lasting infection protection and kills more types of infectious bacteria in laboratory tests than even the leading topical prescription antibiotic. Plus, NEOSPORIN® Original First Aid Antibiotic Ointment and a bandage help heal minor wounds four days faster than a bandage alone and may help min...

Microbiotix, Inc.

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company currently has four novel compound series in research and development. Microbiotix currently has in development MBX 500, the first antibiotic that targets the DNA po...

GeneTel Laboratories

GeneTel Laboratories provides quality research reagents, lab plastic wares, antibody products and high-throughput proteomic antibody production services to the global life science research and biotech as well as pharmaceutical industries. The company combines high quality custom services with large-scale generation of antibodies against deduced peptides of gene and gene segments from the genome pr...

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’s Mission Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving ...

Discuva

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The company’s innovative proprietary technologies both identify new small molecule drugs against novel bacterial targets and facilitate their progression through to drug candidates ...

AB BIODISK

The AB BIODISK name, company spirit and reputation are based on commitment to the highest standards of science. The company is perhaps best known for its dedication to antimicrobial resistance testing since the early 1950s. The mission left by its scientific founder, Hans Ericsson, Professor of Microbiology at the Karolinska Institute, “to Promote the Rational Use of Antibiotics” has been fait...


More From BioPortfolio on "High Throughput Surveillance Study Antibiotic Resistance Using Automated"

Quick Search

Corporate Database Quicklinks